Skip to main content
Premium Trial:

Request an Annual Quote

Omicia Wins $788K NHGRI Grant to Refine Disease Marker Annotation System

NEW YORK (GenomeWeb News) — Omicia has been awarded a $788,517 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute to help it refine its disease marker genome-annotation system, the firm said today.
According to Omicia, the goal of the project is  to “facilitate the development of diagnostic profiles for a diverse array of disease conditions.”
Privately held Omicia said that the system uses information from databases that catalog genetic variations to computationally map clinical disease information directly onto the human genome sequence.
The company received a $99,757 Phase I SBIR grant last year to help it develop the system.